ABSTRACT
The whole plant of the methanolic extract from Leucas cephalotes was screened for invitro antioxidant (using the DPPH method), invivo analgesic (using hot plate test in mice) and anti-inflammatory (using rat paw edema test) activities. The methanolic extract of Leucas cephalotes (MELC) scavenged the DPPH radicals in a dose-dependent manner. The IC50 value to scavenge DPPH radicals was found to be 421.3µg/ml. A significant (p<0.0005) analgesic activity was observed at 60 min with 200 mg/kg, and 400 mg/kg exhibited maximum activity. The maximum anti-inflammatory response was produced at 3 hr and 2 hr with doses of 200 and 400 mg/kg, respectively. These results suggest that the methanolic extract from Leucas cephalotes exerts significant analgesic and anti-inflammatory effects, which were comparable with standard drugs.
O extrato metanólico total de Leucas cephalotes foi submetido à triagem para as atividades antioxidante in vitro (utilizando o método DPPH), analgésica (utilizando teste da placa quente, em camundongos) e antiinflamatória (utilizando teste de edema da pata de rato), nas doses de 200 e 400 mg/kg. O extrato metanólico de Leucas cephalotes (MELC) inativou radicais difenil picril hidrazila (DPPH) de forma dose-dependente. O IC50 para essa atividade foi de 421,3 µg/mL. Observou-se atividade analgésica significativa (p<0,0005) a 60 minutos, com 200 mg/kg, e, com 400 mg/kg, observou-se atividade máxima. A resposta antiinflamatória máxima foi produzida, respectivamente, em 3 h e 2 h, com doses de 200 e 400 mg/kg. Estes resultados sugerem que o extrato metanólico de Leucas cephalotes apresenta efeitos analgésico e antiinflamatório significativos, comparáveis aos fármacos padrão.
Subject(s)
Animals , Male , Female , Mice , Rats , Anti-Inflammatory Agents , Analgesics/analysis , Antioxidants/analysis , Lamiaceae/chemistry , Analysis of Variance , Data Interpretation, StatisticalABSTRACT
The present study was aimed at evaluating the potential toxicity and the general mechanism involved in multi wall carbon nanotubes (MWCNT)-induced cytotoxicity using human embryonic kidney cell line (HEK293) cells. Two multi wall carbon nanotubes (coded as MWCNT1, size: 90-150nm and MWCNT2, size: 60-80nm) used in this study are MWCNT1 (produced by the electric arc method and size of the nanotubes was 90-150nm) and MWCNT2 (produced by the chemical vapor deposition method with size of 60-80nm). To elucidate the possible mechanisms of MWCNT induced cytotoxicity, cell viability, mitochondrial function (MTT assay), cell membrane damage (LDH assay), reduced glutathione (GSH), interleukin-8 (IL-8) and lipid peroxidation levels were quantitatively assessed under carbon nanotubes exposed (48h) conditions. Exposure of different sizes of two carbon nanotubes at dosage levels between 3 and 300mug/ml decreased cell viability in a concentration dependent manner. The IC(50) values (concentration of nanoparticles to induce 50% cell mortality) of two (MWCNT1, MWCNT2) nanoparticles were found as 42.10 and 36.95mug/ml. Exposure of MWCNT (10-100mug/ml) to HEK cells resulted in concentration dependent cell membrane damage (as indicated by the increased levels of LDH), increased production of IL-8, increased TBARS and decreased intracellular glutathione levels. The cytotoxicity and oxidative stress was significantly more in MWCNT2 exposed cells than MWCNT1. In summary, exposure of carbon nanotubes resulted in a concentration dependent cytotoxicity in cultured HEK293 cells that was associated with increased oxidative stress.
Subject(s)
Kidney/drug effects , Kidney/metabolism , Nanoparticles/toxicity , Nanotubes, Carbon/toxicity , Oxidative Stress/drug effects , Carbon/metabolism , Cell Line , Cell Survival/drug effects , Cytoplasm/metabolism , Glutathione/metabolism , Humans , Interleukin-8/metabolism , Kidney/cytology , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation/drug effects , Mitochondria/metabolism , Oxides/metabolismABSTRACT
Atherosclerosis is a disease affecting arterial blood vessels due to the accumulation of macrophage white blood cells and low density lipoproteins. Effects of atorvastatin, a recently introduced lipid lowering statin was studied alone and in combination with clopidogrel in high fat diet fed atherosclerotic rats orally. Results showed significant reduction in total serum cholesterol and malondialdehyde levels and significant improvement in urine creatinine levels. Aortic cross sections of rats treated with clopidogrel alone showed reversal of atherosclerotic calcification. The same effect was observed with the combined treatment of clopidogrel and atorvastatin. Only atorvastatin treatment did not show any histological atheroprotective effect. Atorvastatin and clopidogrel alone and in combination have offered significant atheroprotective effect. No specific advantage was seen with combined treatment of atorvastatin and clopidogrel, moreover the advantages seen with independent drug administration also reduced with combined treatment.
